Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Rationale for Enteral vs Parenteral
Indications
Modes of delivery
Complications
From Townsend CM: Sabiston Textbook of Surgery, 19th edition (Saunders 2012)
Surgical patients with suboptimal nutritional support have impaired wound healing, altered immune responses, accelerated catabolism, increased organ dysfunction, delayed recovery, and increased morbidity and mortality. Following surgery, patients who are inadequately fed become undernourished within 10 days and display a marked increase in mortality. Feeding should therefore be initiated as early as possible, address elevated nutritional demands, and offset any pre-existing nutritional impairment. The ultimate goal of perioperative nutritional management is to supplement caloric and nutrient-specific requirements safely to promote wound healing, diminish risk of infection, and prevent loss of muscle protein.
Nutritional support should be considered for all patients according to clinical assessment and guidelines over the perioperative period ( Box 64-1-1 ). If a surgical intervention can be delayed, 10 to 14 days of nutritional support for patients with severe nutritional risk has been shown to be beneficial prior to surgery. Obviously critical patients and those with a significant loss in body weight or a premorbid state should receive support almost immediately (<3 days) after admission, because they often exhibit immunologic impairment and are at increased risk of infection. Significant weight loss in these patients is often associated with a reduced chance of survival. Malnourished surgical patients also have severely impaired wound healing times. In addition to requiring nutritional support, severely hypercatabolic patients may require therapeutic interventions and rehabilitation exercise programs to regain muscle mass.
Severe nutritional risk expected with at least one of the following:
Past medical history: severe undernutrition, chronic disease.
Involuntary loss >10%–15% of usual body weight within 6 mo or >5% within 1 mo
Expected blood loss >500 mL during surgery
Weight of 20% under IBW or BMI <18.5 kg/m 2
Failure to thrive on pediatric growth and development curves (<5th percentile or a trend line crossing two major percentile lines)
Serum albumin <3.0 g/dL or transferrin <200 mg/dL in the absence of an inflammatory state, hepatic dysfunction, or renal dysfunction
Anticipate that patient will be unable to meet caloric requirements within 7–10 days perioperatively.
Catabolic disease (e.g., significant burns or trauma, sepsis, and pancreatitis)
After a decision to initiate support has been reached, a route of administration should be carefully selected, with the following considerations ( Fig. 64-1-1 ) :
Use the oral route if the GI tract is fully functional and there are no other contraindications to oral feeding.
Initiate nutrition via the enteral route if the patient is not expected to be on a full oral diet within 7 days post-surgery and there are no GI tract contraindications ( Box 64-1-2 ).
Intractable vomiting, diarrhea refractory to medical management
Paralytic ileus
Distal high-output intestinal fistulas (too distal to bypass with feeding tube)
GI obstruction, ischemia
Diffuse peritonitis
Severe shock or hemodynamic instability
Severe GI hemorrhage
Severe short bowel syndrome (less than 100 cm of small bowel remaining)
Severe GI malabsorption (e.g., enteral nutrition failed, as evidenced by progressive deterioration in nutritional status)
Inability to gain access to GI tract
Need is expected for <7 days
If the enteral route is contraindicated or not tolerated, use the parenteral route within 24 to 48 hours in patients who are not expected to be able to tolerate full enteral nutrition (EN) within 7 days.
Administer at least 20% of the caloric and protein requirements enterally while reaching the required goal with additional PN.
Maintain PN until the patient is able to tolerate 75% of calories through the enteral route and EN until the patient is able to tolerate 75% of calories via the oral route.
Early (24 to 48 hours) institution of EN following major surgery minimizes the risk of undernutrition and can abate the hypermetabolic response seen after surgery. Administration of EN can be accomplished via various routes, including the use of nasogastric (NG), nasoduodenal, and nasojejunal tubes ( Fig. 64-1-2 ), which are preferentially used in patients who are expected to require support for short time periods (<4 weeks). Other surgical options include open or percutaneous gastrostomy and jejunostomy, usually for those patients who are expected to require long-term EN (>4 weeks). In general, EN offers the beneficial effects of trophic feedings, which include structural maintenance and functional support of the intestinal mucosa, achieved by providing nutrients such as glutamine, preserving blood supply, and promoting peristalsis. Use of EN to protect and maintain the integrity of the intestinal mucosa may therefore help reduce the risk of sepsis caused by bacterial translocation. Feeding routes for the delivery of EN are described in Table 64-1-1 .
Route | Suitability | Insertion Method, Confirmation | Advantages | Disadvantages |
---|---|---|---|---|
Nasogastric | Short term – functional GI tract | Blind at bedside; fluoroscopy guided | Easy to insert, replace; can monitor gastric pH and residual volume; bolus feeding | Aspiration risk, misplacement complications, sinusitis, epistaxis, nasal necrosis, esophageal strictures, erosive esophagitis |
Nasoduodenal, nasojejunal | Short term – functional GI tract but poor gastric emptying, reflux, aspiration risk; commence feed only when volume-resuscitated and hemodynamically stable | Blind at bedside; fluoroscopy guided, endoscopy guided | Reduced aspiration risk; some tubes enable decompression of stomach while feeding into jejunum | Easily clogged or displaced, aspiration risk, misplacement complications, displacement and reflux into stomach, sinusitis, epistaxis, nasal necrosis; requires continuous infusion; cannot check gastric residuals except with specialized gastric port |
Gastrostomy | Long term – good gastric emptying; avoid if significant reflux or aspiration problem | Surgical, percutaneous, endoscopic, radiologic | Bolus feeding; large-bore tube less likely to block | Procedure risks include bleeding, perforation, aspiration risk, dislodgment with peritoneal contamination, wound site infection, granulation |
Jejunostomy | Long term – functional GI tract but poor gastric emptying, reflux, aspiration risk, gastroparesis or gastric dysfunction | Surgical, percutaneous, endoscopic, radiologic | Reduced aspiration risk | Bleeding, infection, perforation, migration, aspiration, dislodgement and leakage into peritoneal cavity, occlusion, pneumatosis, intestinal ischemia or infarction, bowel obstruction; difficult to replace; cannot check residuals; requires continuous infusion |
In the critically ill patient, EN should be initiated within 48 hours of injury or admission; average intake delivered within the first week should be at least 60% to 70% of the total estimated energy requirements, as determined by the assessment. Provision of EN in this time frame and at this level may be associated with decreased length of hospital stay, days on mechanical ventilation, and infectious complications.
Feeding through a NG tube is the most cost-effective method for EN support and perhaps the most helpful for preventing postoperative complications, such as gastroparesis. The use of NG tubes conveniently facilitates the ability to supply caloric needs and to monitor the volume of gastric residuals. To decrease reflux and the risk of aspiration, it is recommended that the head of the bed be raised to 45 degrees and the volume of residuals not exceed 50 mL/hour. Although the residual volume should be rechecked after 1 hour from a single elevated value, feeding does not have to stop automatically.
GI ileus may reflect an underlying deterioration; therefore, monitoring gastric residual volumes serves as an indicator of intercurrent conditions, such as sepsis. In burn patients, residuals that increase above the amount of food delivered routinely every hour have been shown to correlate with the development of bacterial sepsis, and a full sepsis workup is indicated when gastric residuals exceed 200 mL.
The practice of checking the positioning of tubes by X-ray prior to their use is a time-consuming process that has been motivated, in part, by the unintended placement of small-diameter tubes into lower airways. However, NG tubes may be placed with confidence by auscultation over the stomach while delivering 50 mL of air quickly with an irrigation syringe. Nasojejunal and duodenal tubes may be too small for this procedure. Contraindications to EN include prolonged ileus or gastroparesis, bowel obstruction, acute pseudo-obstruction, ischemic enterocolitis, and other causes of malabsorption.
With nasoenteric feeding beyond the stomach, the tube should be advanced through the duodenum, ideally past the ligament of Treitz to the proximal jejunum, because this reduces the risk of aspiration. Nasojejunal feeding may be preferable in some settings because it does not need to be stopped prior to surgery to prevent aspiration. However, nasojejunal feeding requires continuous infusion, and gastric residual volumes cannot be checked to confirm progress. Nasojejunal feeding should not be commenced until the patient is fully volume-resuscitated and hemodynamically stable. Percutaneous feeding options should be considered if a patient requires nasal tube feeding for a prolonged period beyond 2 or 3 weeks.
Ileus associated with severe injury is not as common as previously thought. Ileus derived from mesenteric hypoperfusion prior to adequate resuscitation is reversed once the patient has been resuscitated. Conversely, over-resuscitation leads to GI edema and should also be avoided. Postinjury ileus does not affect the small bowel as profoundly as the stomach. Therefore, feeding using a nasoduodenal tube passed through the pylorus, or a nasojejunal tube advanced past the ligament of Treitz, can be initiated as soon as possible, preferably within 6 hours following injury. This approach also allows continuous feeding during surgeries and physical therapy sessions. The initiation of immediate enteral feeding allows the delivery of calculated caloric requirements by the third day postinjury. Reduction of hypermetabolism by initiating enteral feeding soon after injury is possible, with this reduction in metabolic rate associated with less intense elevations in glucagon, cortisol, and catecholamine levels.
Numerous enteral formulations are available and can be classified according to their composition. Standard formulas are sterile, nutritionally complete, and intended for patients with a normal GI tract who cannot ingest adequate nutrients and calories by regular oral diets. Specialty formulations may be more efficiently absorbed in patients suffering from short gut syndrome, severe trauma, burn injury, and chronic malabsorptive diarrhea. Whole-protein formulations are appropriate for most patients. Peptide-based or free amino acid formulations may be considered for patients with a severely compromised GI tract or severe protein-fat malabsorption. Modular formulas consist of a singular macronutrient as a source of calories (e.g., fiber, protein) and are generally used by mixing with standard or specialty formulas. Immune-enhancing formulas consist of nutritional components enriched with arginine, glutamine, nucleotides, and omega-3 fatty acids. Although most formulations are hyperosmolar at full strength, dilution by 25% to 50% to make isotonic and hypotonic formulas is initially preferred to minimize the possibility of diarrhea from excess osmotic load and to facilitate absorption ( Table 64-1-2 ). Continuous enteral feeding with milk or a soy-based milk substitute can maintain total body weight throughout the hospital course but may not be able to maintain lean body mass.
COMPOSITION | ||||||
---|---|---|---|---|---|---|
Formula | kcal/mL | CHO, g/L (% Calories) | PRO, g/L (% Calories) | Fat, g/L (% Calories) | Osmolarity (mOsm/L) | Comments |
Standard | ||||||
Similac | 0.67 | 72 (43) | 15 (8) | 36 (49) | Infant nutrition | |
Enfamil | 0.67 | 73 (44) | 14 (8) | 35 (48) | Infant nutrition | |
Isomil | 0.67 | 68 (41) | 18 (10) | 37 (49) | Infant nutrition, lactose-free, used in cow protein allergy | |
Isosource HN | 1.2 | 160 (53) | 53 (18) | 39 (29) | 490 | High nitrogen |
Ensure Plus | 1.5 | 208 (57) | 54 (15) | 46 (28) | 680 | Concentrated calories |
Pediasure Enteral | 1.0 | 133 (53) | 30 (12) | 40 (35) | 335 | For ages 1–13 yr, with fiber, not easily digestible |
Jevity 1 Cal | 1.06 | 155 (54) | 44 (17) | 35 (29) | 300 | Isotonic nutrition with fiber |
Boost Kid Essential | 1.0 | 135 (54) | 30 (12) | 38 (34) | 550–600 | Oral or tube feeding |
Boost HP | 1.0 | 137 (55) | 62 (24) | 25 (21) | 650 | Oral or tube feeding, high protein |
Promote | 1.0 | 130 (52) | 62 (25) | 26 (23) | 340 | High protein, oral or tube feeding |
Promote w/Fiber | 1.0 | 138 (50) | 62 (25) | 28 (25) | 380 | Very high protein, oral or tube feeding |
Nutren 1.0 | 1.0 | 127 (51) | 40 (16) | 38 (33) | 370 | With fiber, decreases diarrhea |
Immune-Enhancing | ||||||
Crucial | 1.5 | 89 (36) | 63 (25) | 45 (39) | 490 | With ARG, critical illness, major surgery, transitional feedings, hydrolyzed protein |
Impact | 1.0 | 130 (53) | 56 (22) | 28 (25) | 375 | With ARG, GLN, and fiber |
Impact GLN | 1.3 | 150 (46) | 78 (24) | 43 (30) | 630 | Immunonutrition, GLN, ARG, omega-3 PUFA, nucleic acids |
Oxepa | 1.5 | 105 (28) | 63 (17) | 94 (55) | 535 | ARDS, acute lung injury, sepsis; concentrated |
Specialty | ||||||
Glucerna | 1.0 | 96 (34) | 42 (17) | 54 (49) | 355 | For glucose-intolerant or diabetic patients, low CHO |
Nepro | 1.8 | 167 (34) | 81 (18) | 96 (48) | 585 | For CKD and patients on dialysis; concentrated |
Osmolite 1 Cal | 1.06 | 144 (54) | 44 (17) | 35 (29) | 300 | Isotonic, for use in those intolerant to hyperosmolar nutrition |
Vivonex RTF | 1.0 | 175 (70) | 50 (20) | 12 (10) | 630 | Transitional feeding, low fat, easily digestible |
Vivonex TEN | 1.0 | 210 (82) | 38 (15) | 2.8 (3) | 630 | 100% free amino acids, very low fat, used for severe trauma (e.g., burns) or surgery, transitional feeding |
Vivonex Plus | 1.0 | 190 (76) | 45 (18) | 6.7 (6) | 650 | 100% free amino acids, very low fat, used for severe trauma (e.g., burns) or surgery, transitional feeding |
Elecare | 0.67 | 72 (43) | 20 (15) | 32 (42) | 350 | Prepared at 9.4 g/60 mL; amino acid-based nutrition |
Modular | ||||||
Resource Benefiber | 0.27 | 66 (100) | 0% | 0% | – | Prepared at 4 g/60 mL; tasteless, odorless, soluble fiber, used for constipation |
Resource Beneprotein | 0.83 | 0% | 200 (100) | 0% | – | Prepared at 7 g/30 mL; whey protein, mixed in foods, protein-calorie malnutrition |
* Data extrapolated from Nestle Clinical Nutrition: Enteral product reference guide, Nestle, 2010, Minneapolis; and Abbott Laboratories: Abbott nutrition pocket guide, Abbott Park, Ill, 2009, Abbott Laboratories.
In patients undergoing a severe hypermetabolic response, peripheral breakdown of fat is increased. Fatty acids are delivered to the liver and undergo re-esterification; their accumulation leads to fatty liver changes. The use of high-fat diets such as milk, which consists of 44% fat, 42% carbohydrate, and 14% protein, needs to be carefully considered because additional fat may lead to increased levels of fat in the liver. The use of high-sugar, high-protein diets consisting of 3% fat, 82% carbohydrate, and 15% protein stimulate protein synthesis, increase endogenous insulin production, and improve lean body mass accretion.
Muscle protein degradation is markedly decreased with the administration of a high-carbohydrate diet compared with fat-containing diets. Endogenous insulin concentration is increased, improving the net balance of skeletal muscle protein caused by decreased protein breakdown.
Complications of nasogastric and enteric feeding include nausea and vomiting, epistaxis, sinusitis, nasal necrosis, aspiration leading to pneumonia, tube malpositioning, dislodgment, and feeding-associated diarrhea. Fine-bore tubes are more comfortable but can become blocked easily. Auscultation examination of gastric fluid aspirate and pH testing can be used to confirm tube position, particularly for large-bore nasal tubes, although many units prefer radiologic confirmation. Tubes can also be inserted under endoscopic or fluoroscopic guidance. Monitoring guidelines and potential metabolic complications of EN are given in Tables 64-1-3 and 64-1-4 .
Parameter | Acute Patient | Stable Patient |
---|---|---|
Electrolytes | Daily | 1–2×/week |
Complete blood count | Daily | 1–2×/week |
Glucose level | 3×/day; more often if poor control | 3×/day; less often if good control |
Creatinine and urea levels | Daily | Weekly or twice weekly |
Nitrogen balance | Daily | 2–3×/week |
Input and output | Daily | 2–3×/week |
Body weight | Daily | 2–3×/week |
Urine output | Hourly | every 4 hours |
Stool | Per motion | Daily |
Problem | Common Causes | Management |
---|---|---|
Diarrhea | Medications (e.g., antibiotics, H 2 blockers, laxatives, hyperosmotic, hypertonic solutions), feeding intolerance (osmolarity, fat), acquired lactase deficiency |
|
Nausea and vomiting | Delayed stomach emptying, constipation, abdominal distention, odor and appearance of formulations |
|
Constipation, fecal impaction | Dehydration, lack or excess of fiber |
|
Aspiration pneumonitis | Long-term supine position, delayed stomach emptying, altered mental status, malpositioned feeding tube, vomiting |
|
Hyponatremia overhydration | Excess fluid intake, refeeding syndrome, organ failure (e.g., liver, heart, kidney) |
|
Hypernatremia | Dehydration, inadequate fluid intake | Increase free water. |
Dehydration | Diarrhea, inadequate fluid intake |
|
Hyperglycemia | High content of carbohydrate in feedings, insulin resistance |
|
Hypokalemia, hypophosphatemia, hypomagnesemia | Diarrhea, refeeding syndrome |
|
Hyperkalemia | Excess potassium intake, renal impairment |
|
Refeeding syndrome can be precipitated following prolonged fasting and IV fluid administration in chronically malnourished patients. The transition from metabolizing body fat to carbohydrate in the feed can cause an abrupt rise in insulin and disturbances of intracellular electrolytes. Electrolyte abnormalities can result in cardiac failure and dysrhythmias, respiratory failure, neurologic disturbances, and renal and hepatic dysfunction. With all nutritional support, the rate of feeding should commence slowly to prevent abrupt metabolic changes.
Aside from mechanical issues related to the feeding tube, the most common complications of enteral feedings result from solute overload. Inappropriately rapid administration of hyperosmolar solutions may result in diarrhea, dehydration, electrolyte imbalance, hyperglycemia, and loss of potassium, magnesium, and other ions through diarrhea. If aggressive administration of hyperosmolar solute continues, pneumatosis intestinalis with bowel necrosis and perforation can result. Hyperosmolar nonketotic coma can also occur with enteral feedings, as with PN.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here